The result displayed that Phillyrin administration drastically reversed increased HGP under obesity (Figure 3F), associated with decreased expression of glycolytic gene G6pc in the liver (Figure 3G), the rate-limiting enzyme driving gluconeogenesis in HFD-fed mice. The gene discussed is G6PC1; the disease is Obesity.